Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection.
Li
J
J
Department of Clinical Sciences, The Institute of Liver Studies, Guy's, King's and St Thomas' School of Medicine, King's College Hospital, London, UK.
Collins
L
L
Zhang
X
X
Gustafsson
K
K
Fabre
J W
JW
D000818:Animals; D002908:Chronic Disease; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000008:administration & dosage*; D006084:Graft Rejection / Q000628:therapy*; D006801:Humans; D016023:Integrins / Q000235:genetics*; D008565:Membrane Proteins / Q000235:genetics*; D009131:Muscle, Smooth, Vascular; D010455:Peptides / Q000008:administration & dosage*; D014184:Transplantation, Homologous
D016023:Integrins; D008565:Membrane Proteins; D010455:Peptides